Related Experiment Video
Updated: Sep 26, 2025

Replication of the Ordered, Nonredundant Library of Pseudomonas aeruginosa strain PA14 Transposon Insertion Mutants
Published on: May 4, 2018
Risk Factors for Carbapenem-resistant Pseudomonas aeruginosa Infection in Children
Lu Li1, Yanfeng Huang1, Qiqin Tang1
1From the Department of Infectious Children's Hospital of Chongqing Medical University, National Clinical Research Center for Child Health and Disorders, Ministry of Education Key Laboratory of Child Development and Disorders, Chongqing Key Laboratory of Pediatrics, Chongqing, China.
Insights
Carbapenem-resistant Pseudomonas aeruginosa (CRPA) is a growing threat in hospitals. Prior carbapenem exposure and bronchoscopy are key risk factors for CRPA infection in children, necessitating careful antimicrobial stewardship.
Area of Science:
- Medical Microbiology
- Infectious Diseases
- Pediatrics
Background:
- Carbapenem-resistant Pseudomonas aeruginosa (CRPA) presents a significant and increasing threat as a nosocomial infection.
- Identifying risk factors for CRPA infection in pediatric populations is crucial for effective management.
Purpose of the Study:
- To determine the specific risk factors associated with carbapenem-resistant Pseudomonas aeruginosa (CRPA) infection in children.
- To investigate the role of antimicrobial use and invasive procedures in the development of CRPA.
Main Methods:
- A retrospective cohort study was conducted involving pediatric patients with Pseudomonas aeruginosa infection from 2016 to 2020.
- Propensity-score matching was used to compare patients with carbapenem-susceptible PA and CRPA.
- Univariate and multivariate analyses were employed to identify independent risk factors for CRPA.
Main Results:
- Prior exposure to carbapenems (OR: 0.102) and bronchoscopy (OR: 0.147) were identified as independent risk factors for CRPA infection.
- Previous invasive therapy in the last year (OR: 0.353) and recent use of beta-lactams/beta-lactamase inhibitors (OR: 0.327) were also significant risk factors.
- The study analyzed 172 pediatric patients with PA infection.
Conclusions:
- Prior carbapenem exposure and bronchoscopy are significant risk factors for pediatric CRPA infections.
- Invasive therapies and specific antimicrobial use patterns influence the spread of CRPA.
- Clinical use of carbapenems requires careful consideration and potential restrictions to mitigate resistance.
Background:
Carbapenem-resistant Pseudomonas aeruginosa (CRPA) is rapidly emerging as a life-threatening nosocomial infection. The study aimed to identify the risk factors for CRPA infection in children, especially antimicrobials use and invasive procedures.
Methods:
A retrospective study was conducted in the Children's Hospital of Chongqing Medical University, which involved a cohort of patients with PA infection from January 2016 to December 2020. Patients were assigned to a carbapenem-susceptible PA group or to a CRPA group and matched using propensity-score matching. Univariate analysis and multivariate analysis were performed to estimate the risk factors of CRPA.
Results:
One-thousand twenty-five patients were included in the study but 172 children were analyzed. Several factors were associated with CRPA infection according to univariate analysis ( P < 0.05), such as prior treatment with some antimicrobials and invasive procedures. However, only prior exposure to carbapenems (odds ratio [OR]: 0.102; confidence interval [CI]: 0.033-0.312; P < 0.001) and bronchoscopy (OR: 0.147; CI: 0.032-0.678; P = 0.014) during time at risk, previous invasive therapy in the last year (OR: 0.353; CI: 0.159-0.780; P = 0.013), and previous use of β-lactams/β-lactamase inhibitors within the last 90 days (OR: 0.327; CI: 0.121-0.884; P = 0.03) were considered independent risk factors by multivariate analysis.
Conclusions:
Those who had prior exposure to carbapenems and bronchoscopy were high-risk population to develop CRPA infection. The spread of CRPA could be influenced by invasive therapy, and we need pay attention to it. Moreover, we should take restrictions in the clinical use of carbapenems into account.
More Related Videos
07:46Use of Artificial Sputum Medium to Test Antibiotic Efficacy Against Pseudomonas aeruginosa in Conditions More Relevant to the Cystic Fibrosis Lung
Published on: June 5, 2012
11:32Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria
Published on: February 23, 2014
Related Concept Videos
Pneumonia I: Introduction
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Factors Affecting the Risk of Infection
The integrity and count of the white blood cells help the body resist pathogens and fight infection. When impaired, it reduces the body's resistance to pathogens. The acidic pH levels of the gastrointestinal, genitourinary tracts, and skin...
Acute Pyelonephritis I: Introduction
Peritoneal Dialysis II: Peritoneal Dialysis Systems and Complications
Gene Regulation in Microbial Communities: Quorum Sensing
Development of Antibiotic Resistance